Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy
1 other identifier
interventional
71
1 country
1
Brief Summary
The hypothesis is that starting a bowel regimen with Polyethylene Glycol prior to robotic assisted sacrocolpopexy will decrease time to first bowel movement after surgery. The experimental group will take a pre-operative course of polyethylene glycol daily for seven days prior to procedure date. The control group will not be given any intervention preoperatively. All patients will take polyethylene glycol postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Dec 2019
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2019
CompletedStudy Start
First participant enrolled
December 9, 2019
CompletedFirst Posted
Study publicly available on registry
December 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2023
CompletedResults Posted
Study results publicly available
December 27, 2024
CompletedDecember 27, 2024
December 1, 2024
3.5 years
December 9, 2019
October 3, 2024
December 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
First Bowel Movement
Time to first post-operative bowel movement will be evaluated.
7 days post-operatively
Secondary Outcomes (3)
Post Operative Pain With First Bowel Movement as Measured by the VAS Scale.
7 days post-operatively
Post Operative Pain at Day 1 as Measured by the VAS Scale
1 day post-operatively
Median Postoperative Pain
Averaged over 7 days post-operatively
Study Arms (2)
Experimental
EXPERIMENTALThe experimental group will take a pre-operative course of polyethylene glycol daily for seven days prior to procedure date.
Control
NO INTERVENTIONThe control group will not be given any intervention preoperatively.
Interventions
Polyethylene Glycol 3350 17g should be mixed in 8 ounces of fluid for administration. Polyethylene glycol is a high molecular weight, water soluble polymer which can form hydrogen bonds with water molecules. It is an osmotic laxative solution which stimulates bowel movements by increasing the amount of water absorbed in the GI tract. It decreases feces consistency and increases their volume by promoting peristalsis and evacuation. The side effects of polyethylene glycol are bloating, gas or diarrhea. The half-life of polyethylene glycol is 4-6 hours and after 18 hours the concentration declines to non-quantifiable levels.
Eligibility Criteria
You may qualify if:
- Patients undergoing a robotic assisted sacrocolpopexy with or without hysterectomy and with or without anti-incontinence procedures
You may not qualify if:
- Age under 18 or over 90
- Planned laparotomy
- Planned posterior colporrhaphy
- Regular pre-operative use of stool softeners/laxatives
- Presence of colostomy
- Inability to give informed consent
- Inability to take medication by mouth
- Chronic kidney disease (Cr \> 1.2)
- Esophageal strictures
- Persistent nausea and vomiting
- Bowel obstruction
- Inflammatory bowel disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
Study Sites (1)
Northwell Health
Bay Shore, New York, 11706, United States
Related Publications (1)
Holubyeva A, Goodwin AI, O'Shaughnessy D, Pillalamarri N, Demertzis K, Rahbani AC, Stefanov DG, Finamore PS. Does a Preoperative Bowel Regimen Change Time to Bowel Movement? A Randomized Clinical Trial. Urogynecology (Phila). 2024 Mar 1;30(3):251-255. doi: 10.1097/SPV.0000000000001462. Epub 2024 Feb 26.
PMID: 38484239DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Alexandra Goodwin
- Organization
- UCLA Health
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2019
First Posted
December 13, 2019
Study Start
December 9, 2019
Primary Completion
June 21, 2023
Study Completion
June 21, 2023
Last Updated
December 27, 2024
Results First Posted
December 27, 2024
Record last verified: 2024-12